Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.1M
Filings
61
Firms Hired
4
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Generic Drugs. H.R.4128 - VALID Act. H.R.6000 - Cures 2.0.
Client expense: — · Firm income: $50,000
Matched citations: H.R.4128
Generic Drugs. H.R.4128 - VALID Act. H.R.6000 - Cures 2.0.
Client expense: — · Firm income: $50,000
Matched citations: H.R.6000
General issues related to access and reimbursement for cell and gene therapies, HR 7389 - "MVP Act."
Client expense: $90,000 · Firm income: —
Matched citations: HR 7389
Source: Senate LDA